167 results
Page 4 of 9
424B5
bhm7nnkim
2 Oct 20
Prospectus supplement for primary offering
4:24pm
8-K
EX-10.1
s1x6ii u58pyhjjgsc
4 Aug 20
Qualigen Therapeutics, Inc. Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:25pm
8-K
EX-10.4
mbdth0 2p3
4 Aug 20
Qualigen Therapeutics, Inc. Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:25pm
424B5
edb0 ihekqjxevr
4 Aug 20
Prospectus supplement for primary offering
6:16am
8-K
EX-10.1
foc93eyy5ko9mro7lf
10 Jul 20
Qualigen Therapeutics, Inc. Announces Closing of $8 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:40pm
424B5
lgz3y29eg sqs
10 Jul 20
Prospectus supplement for primary offering
2:35pm
8-K
EX-10.1
g742vo7
9 Jul 20
Qualigen Therapeutics, Inc. Announces $8 Million
6:02am
8-K/A
EX-99.1
ku8h h1nxebnm2
29 Jun 20
Index to Financial Statements
12:00am
8-K
EX-10.2
pfjw 6yzqzae6b
29 May 20
Qualigen Therapeutics Announces Merger Closing
5:03pm
8-K
EX-2.4
wj0ntf22bjpb0 bfh
29 May 20
Qualigen Therapeutics Announces Merger Closing
5:03pm
8-K
EX-10.6
iyiqi5ytauir
29 May 20
Qualigen Therapeutics Announces Merger Closing
5:03pm
8-K
EX-10.20
5tmhkm lg
29 May 20
Qualigen Therapeutics Announces Merger Closing
5:03pm
8-K
EX-10.7
70hhihycz0y
29 May 20
Qualigen Therapeutics Announces Merger Closing
5:03pm